About Amogha Tadimety
Amogha Tadimety is Nanopath’s co-founder, co-CEO and a board director. Nanopath develops rapid molecular tests for pelvic and gynecologic infections.
She was Nanopath’s co-founder and CEO in 2022 and 2024.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Amogha Tadimety in the role, so the role may have started earlier or lasted longer.
Nanopath Inc Current
Co-Founder, Co-CEO, Board Director
co-founder and CEO
2022 – Present · Cambridge, MA
Nanopath develops clinic-based molecular tests designed to return actionable infection results during one office visit.
Key Colleagues at Startups
The people Amogha Tadimety works with at each company, as listed on that company's latest Form D.
Nanopath Inc · Form D, Nov 13, 2026
Alison Burklund
Co-Founder, Co-CEO, Board Director
JC
Jeff Crowe
Board Director
Aaron Sandoski
Board Director